Target Details
| UniProt AC | Q14164 |
|---|---|
| Gene Symbol | IKBKE |
| Protein Name | Inhibitor of nuclear factor kappa-B kinase subunit epsilon |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) PF18394 (TBK1_CCD1) PF18396 (TBK1_ULD) |
Summary
- Multi-target molecules 596
- Clinical molecules 14
- Avg pChEMBL 7.38
KEGG Pathways (18)
- Alcoholic liver disease
- C-type lectin receptor signaling pathway
- Chemical carcinogenesis - receptor activation
- Coronavirus disease - COVID-19
- Cytosolic DNA-sensing pathway
- Epstein-Barr virus infection
- Hepatitis B
- Hepatitis C
- Herpes simplex virus 1 infection
- Human papillomavirus infection
- IL-17 signaling pathway
- Influenza A
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- NOD-like receptor signaling pathway
- RIG-I-like receptor signaling pathway
- Toll-like receptor signaling pathway
Active Molecules (596)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
HKIHBMOYFPBKRM
|
7.5 | IC50 | 2 | — | |
LZMAOONJSWWBEC
|
7.5 | IC50 | 2 | — | |
UDUUROZQLWGGJD
|
7.5 | IC50 | 2 | — | |
UXONJEQASGNIRB
|
7.5 | IC50 | 2 | — | |
NHHQJBCNYHBUSI
|
7.4 | Kd | 220 | — | |
PECFUAQQLXEZJY
|
7.4 | IC50 | 2 | — | |
SYMILEXMAHCATG
|
7.4 | IC50 | 4 | — | |
AWDVCHUEOUFQEL
|
7.4 | IC50 | 2 | — | |
BUHBIIPEWPOROL
|
7.4 | IC50 | 2 | — | |
QQLAYKPAOURFQO
|
7.4 | IC50 | 2 | — | |
XSPWFBVBJPGXNR
|
7.4 | IC50 | 2 | — | |
JTBYAWVOSUNWIB
|
7.4 | IC50 | 2 | — | |
JTMNZLVEDRFGHR
|
7.4 | IC50 | 2 | — | |
LDTAHRLHGHFHKP
|
7.4 | IC50 | 3 | — | |
RSUXWNMQQLYBIH
|
7.4 | IC50 | 2 | — | |
RYYNGWLOYLRZLK
|
7.4 | Ki | 104 | — | |
LNMLTSVLONLVTE
|
7.4 | IC50 | 2 | — | |
NLHGPDUHURNAHF
|
7.4 | IC50 | 3 | — | |
DNGHYRYQEMRIDG
|
7.4 | IC50 | 3 | — | |
NOCFKKXWSSCWRO
|
7.4 | IC50 | 2 | — | |
RTLHVWFETKCJMG
|
7.4 | IC50 | 3 | — | |
LHPPCLUNEXZVTH
|
7.4 | IC50 | 2 | — | |
OSVUGUHRKMMBSE
|
7.4 | Kd | 170 | — | |
FOXLRMNNJOHKBL
|
7.3 | IC50 | 2 | — | |
HWCQSDRAAGDSRX
|
7.3 | IC50 | 2 | — | |
ILQIMLNGGBJZNP
|
7.3 | IC50 | 2 | — | |
WPPGTNKIMPNPSA
|
7.3 | IC50 | 2 | — | |
SNJRVUBJSCKVLN
|
7.3 | IC50 | 5 | — | |
VCINJUXSDKRSQQ
|
7.3 | IC50 | 2 | — | |
WHHJYUVJNITNFN
|
7.3 | IC50 | 4 | — | |
WISWDBLLYNYCRE
|
7.3 | IC50 | 2 | — | |
XHNAYNYWJBNROG
|
7.3 | IC50 | 2 | — | |
JSJHGXYXYWXMNC
|
7.3 | IC50 | 2 | — | |
NTPUVYZJBMHFDY
|
7.3 | IC50 | 2 | — | |
OVAKBHHHFBDHMH
|
7.3 | IC50 | 2 | — | |
UVPLHKWZLRJFSX
|
7.3 | IC50 | 3 | — | |
NGFGTMFVWSDFPS
|
7.3 | IC50 | 32 | — | |
ZNZQEKQKXAOGDX
|
7.3 | IC50 | 2 | — | |
RGNHKJWHFIPHIM
|
7.3 | Ki | 66 | — | |
RZQANRRMBKDLGQ
|
7.3 | IC50 | 2 | — | |
SSMPZXRXMBEUFU
|
7.3 | IC50 | 4 | — | |
GUJCSPVLKMVZMJ
|
7.3 | IC50 | 3 | — | |
UBPYILGKFZZVDX
|
7.3 | Kd | 130 | Yes | |
BWKLZGQQSYIAEL
|
7.3 | IC50 | 2 | — | |
SIMRMBMUTPELDR
|
7.3 | IC50 | 2 | — | |
GVEFUAPLXFCYLH
|
7.2 | IC50 | 2 | — | |
HCQISHRTQSDYMG
|
7.2 | IC50 | 2 | — | |
NXSJMRCTGYTSTK
|
7.2 | Kd | 200 | — | |
CZBLMYRJPRLVRE
|
7.2 | IC50 | 3 | — | |
VRYICCMNURPSDI
|
7.2 | IC50 | 3 | — |